Clinical Trials Logo
  1. Home
  2. Healthy Infants
  3. NCT03976596
  4. Details
NCT03976596 Clinical Trial

Measurement of in Vivo Mitochondrial Capacity in Infants

Healthy Infants Clinical Trial

Official title:
Measurement of in Vivo Mitochondrial Capacity in Infants: a 31P-MRS Pilot Study

Clinical Trial Details — Status: Terminated

Administrative data
NCT number NCT03976596
Other study ID # PBRC 2018-051
Secondary ID
Status Terminated
Phase
First received
Last updated
Start date May 21, 2019
Est. completion date July 2, 2019

Study information
Verified date March 2024
Source Pennington Biomedical Research Center
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The overarching aim of this project is to determine the test re-test reliability of 31P-magnetic resonance spectroscopy measurements in infants. Primary endpoints include two separate measures of in vivo mitochondrial capacity (ATPmax) over a 1-10 day period to assess feasibility and reliability.

Recruitment information / eligibility
Status Terminated
Enrollment 2
Est. completion date July 2, 2019
Est. primary completion date July 2, 2019
Accepts healthy volunteers
Gender All
Age group 14 Days to 28 Days
Eligibility Inclusion Criteria: - healthy, full-term infant - aged 14-28 days at Visit 1 - willingness of parents to be notified of incidental findings from study procedures Exclusion Criteria: - born preterm - implanted metal or electronic objects that render MRI unsafe - unable to complete 2 clinic visits 1-10 days apart at Pennington Biomedical Research Center

Study Design

Related Conditions & MeSH terms

Locations
Country Name City State
United States Pennington Biomedical Research Center Baton Rouge Louisiana

Sponsors (1)
Lead Sponsor Collaborator
Pennington Biomedical Research Center

Country where clinical trial is conducted

United States, 

Outcome
Type Measure Description Time frame Safety issue
Primary In vivo mitochondrial capacity (ATPmax) In vivo mitochondrial capacity as measured by phosphorus magnetic resonance spectroscopy 1 day
See also
  Status Clinical Trial Phase
Completed NCT03679234 - Impact of Infant Formula on Caregiver-perceived Intolerance N/A
Completed NCT01681355 - Gastrointestinal Tolerance Study of a New Infant Formula N/A
Completed NCT04962594 - Safety and Efficacy of Infant Formulas Supplemented With Pre- and Probiotic(s) N/A
Completed NCT03722550 - Second Generation Human Milk Oligosaccharides Blend Study N/A
Completed NCT03703583 - Infant Feeding Practice and Gut Comfort Study
Completed NCT01515644 - Study on the Effect of Inulin in Infant Formula on Gut Health Phase 3
Completed NCT03014115 - Effects of Different ARA Formulations of Infant Formula on Fatty Acid Status, Immune Markers and Infection Rates in Infants N/A
Recruiting NCT06053112 - The Trial of a New Infant Formula in Healthy Term Chinese Infants N/A
Completed NCT03000543 - Novel Isotope Dilution Technique to Assess Vitamin A Status N/A
Not yet recruiting NCT06361719 - Efficacy of Two HMOs in Chinese Infants N/A
Recruiting NCT01601197 - A Study of Two Injection Techniques to Reduce Pain in Infants Undergoing Immunization Phase 3
Completed NCT01635816 - Immunogenicity of SA 14-14-2 JE Vaccine Phase 4
Completed NCT01633216 - Poliovirus Vaccine Trial in Bangladesh Phase 4
Completed NCT00957892 - Effects of Infant Formula Composition on Infant Feeding Behaviors N/A
Completed NCT03801161 - Influence of Inflammation on Micronutrient Status Assessment N/A
Active, not recruiting NCT06073652 - Starter Infant Formula With Synbiotics N/A
Completed NCT01825109 - Improving Rotavirus Vaccine Immune Response Phase 3
Withdrawn NCT01507935 - Colonisation Resistance Study Phase 2
Completed NCT01594840 - Changing Chat: Diaper Tips to Improve Language Development N/A
Not yet recruiting NCT01249911 - Lactobacillus Reuteri DSM 17938 and Prevention of Respiratory and Gastrointestinal Infections in Mexican Infants Phase 3